PropertyValue
?:abstract
  • In this retrospective multicenter cohort study, we aimed to investigate the association between antihypertensive agent exposure and in-hospital mortality in patients with Covid-19. Of 8,078 hospitalized patients for Covid-19, 3,686 (45.6%) had hypertension including 2043 (55.4%) patients exposed to a renin-angiotensin-aldosterone inhibitors (RAASi), 1624 (44.1%) to calcium channel blockers (CCB) and 1154 (37.7%) to beta-blockers. Overall in-hospital 30-day mortality was 23.1%. Compared to non-users, the risk of mortality was lower in CCB (aOR, 0.83 [0.70-0.99]) and beta-blockers users (aOR, 0.80 [0.67-0.95]), and not different in RAASi users. These findings support the continuation of antihypertensive agents in patients with Covid-19.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1101/2020.11.23.20237362
?:license
  • medrxiv
?:pdf_json_files
  • document_parses/pdf_json/d736f0491902fc31dc8ddb1a66fd2e3da87388be.json
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • MedRxiv; WHO
?:title
  • Association of antihypertensive agents with the risk of in-hospital death in patients with Covid-19
?:type
?:year
  • 2020-11-24

Metadata

Anon_0  
expand all